The Vaccine Group
PrivateLast Round
Grant
Oct 17, 2024
Est. Valuation
$12.35M
Total Funding Raised
$2.65M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
The Vaccine Group operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Grant round in October 2024.
The Vaccine Group is a biotechnology company that develops recombinant viral-vector vaccines and biotherapeutics for livestock and companion animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
The Vaccine Group Comparables
Compare The Vaccine Group with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ViroVet | 83% | |
| Genvax Technologies | 81% | |
| AAVACC Pte. Ltd. | 79% |
For institutional investors. Book with your work email.
The Vaccine Group Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 17, 2024 | ||||
| Grant | Oct 14, 2024 | ||||
| Grant | Sep 5, 2024 | ||||
| Seed | Jan 20, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
The Vaccine Group Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Frontier IP Group Plc | Seed |
| Innovate UK | Grant |
| Department for Environment, Food & Rural Affairs | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 37% MoM.
- Oct 29, 2024
Monthly visitors grew 218% MoM, from 377 to 1.2K.
For institutional investors. Book with your work email.
The Vaccine Group Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about The Vaccine Group's valuation, stock price, and market status.
Is The Vaccine Group a public or private company?
The Vaccine Group is a private company.
What is the current stock price of The Vaccine Group?
The Vaccine Group is a private company, so its shares have no public market price. Caplight tracks The Vaccine Group's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is The Vaccine Group worth (valuation)?
The Vaccine Group's valuation is estimated at $12.3M based on funding round data.
Can I buy The Vaccine Group stock?
The Vaccine Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was The Vaccine Group's last funding round?
The Vaccine Group's most recent funding round was Grant on October 17, 2024.
Who are the main investors in The Vaccine Group?
Key investors in The Vaccine Group include Frontier IP Group Plc, Innovate UK, Department for Environment, Food & Rural Affairs.
Will The Vaccine Group IPO soon?
No public IPO plans have been announced for The Vaccine Group.
How can I track The Vaccine Group secondary market activity?
Caplight tracks bids, offers, and trades in The Vaccine Group's shares on secondary markets.